By equipping bacteriophages with the gene-editing system CRISPR, researchers have been able to sensitize drug-resistant bacteria to antibiotics. And by combining that sensitization with enhanced resistance to a second separate phage, the team was able to forestall the development of resistance against the first phage – which left the bacteria vulnerable to antibiotics but did not kill them outright.